Effect of Fruit Smoothie Supplementation on Psychological Distress Among People Receiving Opioid Agonist Therapy
NCT05229770 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 324
Last updated 2025-08-08
Summary
Background: People with substance use disorders generally have poor diets including limited intake of fruit and vegetables. Evidence shows substantial health benefits from increasing fruit and vegetable consumption on a variety of indicators and possibly also psychological distress. A pilot study has indicated that supplementation with fruit smoothie could be promising also among people receiving opioid agonist therapy (OAT) for opioid dependence. FruktBAR will compare the efficacy of fruit smoothie supplementation within the OAT clinics compared to standard treatment.
Study design: FruktBAR is a multicentre, randomised controlled trial. The trial will recruit approximately 230 patients receiving OAT in Bergen and Stavanger, Norway.
Intervention: The intervention involves daily supplementation with 250 ml fruit smoothie. The main endpoints are 16 weeks after intervention initiation. Participants will be included and followed up during and after intervention.
Study population: The target group will be patients with opioid dependence receiving OAT from involved outpatient clinics in Bergen and Stavanger.
Expected outcome: This study will inform on the relative advantages or disadvantages of a fruit supplementation in addition to the current medically and psychologically oriented treatment of people receiving opioid agonist therapy. If the supplementation is found to be safe and efficacious, it can be considered for further scale-up.
Conditions
- Substance-Related Disorders
Interventions
- DIETARY_SUPPLEMENT
-
Fruit smoothie
Participants randomised to the intervention arm will receive a 250 ml fruit smoothie as diet supplement for 20 weeks in addition to the regular OAT clinic follow-up. The fruit smoothies will be marketed products including combinations of the following fruits: apple, pineapple, mango, bananas, orange, blueberries, passion fruit, coconut, lime, and blackcurrant. The participants will receive a mixture of different smoothie types with the option of removing alternatives based on preferences. Fruit smoothie products will come in plastic bottles and will be delivered directly to the participants on a weekly basis. Each participant will receive a total of seven smoothie bottles per week with an oral agreement with each participant to consume one of these per day. Delivery of fruit smoothie will generally be given in parallel with delivery of OAT medication.
Sponsors & Collaborators
-
Helse Stavanger HF
collaborator OTHER_GOV -
Helse Vest
collaborator OTHER -
University of Bergen
collaborator OTHER -
University of Oslo
collaborator OTHER -
Haukeland University Hospital
lead OTHER
Principal Investigators
-
Lars Fadnes, PhD · Haukeland University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-07
- Primary Completion
- 2023-10-01
- Completion
- 2025-03-15
Countries
- Norway
Study Locations
More Related Trials
-
Effects of Commonly Used Medications on Mood and Choice
NCT03652740 ·Status: COMPLETED ·Phase: PHASE1
-
How Stress Alters Opioid Drug Effects
NCT06485817 ·Status: COMPLETED ·Phase: NA
-
Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder
NCT04231708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
PHAST: Physical Activity in Substitution Therapy
NCT02309021 ·Status: COMPLETED ·Phase: NA
-
Cannabioids as a New Intervention for Amphetamine Dependence
NCT02952196 ·Status: WITHDRAWN ·Phase: PHASE2
-
Nitrous Oxide- Suicidal Ideation
NCT03736538 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Neuromodulation and Cognitive Training in Opioid Use Disorder
NCT03773523 ·Status: RECRUITING ·Phase: NA
-
Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents
NCT04336605 ·Status: UNKNOWN
-
N-acetylcysteine for the Treatment of Cannabis Dependence: Working Mechanisms
NCT03221231 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication
NCT06629740 ·Status: COMPLETED ·Phase: NA
-
Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers
NCT05235503 ·Status: UNKNOWN ·Phase: PHASE4
-
Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug Users
NCT05886504 ·Status: COMPLETED ·Phase: NA
-
Acute Dose-dependent Effects of DMT in Healthy Subjects
NCT05384678 ·Status: COMPLETED ·Phase: PHASE1
-
Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity
NCT02557984 ·Status: COMPLETED ·Phase: NA
-
Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
NCT00000252 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of the Prosocial and Prosexual Effects of GHB
NCT02342366 ·Status: COMPLETED ·Phase: NA
-
Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects
NCT03717272 ·Status: COMPLETED ·Phase: PHASE2
-
Ovarian Hormones and Stress Induced Drug Craving
NCT02098434 ·Status: COMPLETED ·Phase: NA
-
Antidepressant Response of DMT Masked With Propofol
NCT06927076 ·Status: RECRUITING ·Phase: NA
-
Marijuana Drug Discrimination and Self-Administration
NCT00943930 ·Status: COMPLETED
-
Personality Disorders and Substance Use Disorders in a Sexual Context in the Man Having Sex With Other Men Population
NCT03753737 ·Status: COMPLETED
-
Effects of Hallucinogens and Other Drugs on Mood and Performance
NCT02033707 ·Status: COMPLETED ·Phase: PHASE1
-
Measuring Acute Drug Demand in Humans
NCT05829655 ·Status: SUSPENDED ·Phase: EARLY_PHASE1
-
The Human Stress Response in a Simulated ED Setting
NCT04317482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Dose Response of Mirtazapine to Methamphetamine Induced Interest, Mood Elevation and Reward
NCT00600145 ·Status: WITHDRAWN ·Phase: NA